Skip to content

Comparison of General Anesthesia Combined with Intrathecal Morphine versus General Anesthesia Combined with Continuous Epidural Analgesia in Patients Undergoing Colorectal Cancer Surgery: A Randomized Controlled Trial

Comparison of General Anesthesia Combined with Intrathecal Morphine versus General Anesthesia Combined with Continuous Epidural Analgesia in Patients Undergoing Colorectal Cancer Surgery: A Randomized Controlled Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260128004
Enrollment
120
Registered
2026-01-28
Start date
2025-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute postoperative pain following elective open colorectal cancer resection surgery, including inadequate pain control, opioid-related adverse effects, and optimization of neuraxial analgesia techniques Intrathecal morphine, Epidural analgesia, Colorectal cancer surgery, Postoperative pain, Pain management, Neuraxial analgesia, Opioid consumption, Patient satisfaction, Randomized controlled trial

Interventions

Patients in this arm receive intrathecal morphine 0.2mg (preservative-free) administered via spinal needle at L3-4 or L4-5 interspace before induction of general anesthesia. Following surgery, patient
Active Comparator Procedure/Surgery,Active Comparator Procedure/Surgery
Intrathecal Morphine (ITM),Epidural Analgesia (EPI)

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Age 18-75 years 2.ASA physical status I-III 3.Diagnosed with colorectal cancer requiring surgical resection 4.Scheduled for elective open colorectal surgery under general anesthesia 5.Able to understand and use Visual Analog Scale (VAS) for pain assessment 6.Able to provide written informed consent 7.Willing to comply with study protocol and follow-up procedures

Exclusion criteria

Exclusion criteria: 1.Patient refusal to participate in the study 2.Inability to provide informed consent 3.Emergency or urgent surgery 4.ASA physical status IV-V 5.Contraindications to neuraxial anesthesia: 6.Allergy or contraindications to study medications: 7.Known hypersensitivity to morphine, bupivacaine, or fentanyl 8.Allergy to other opioids or local anesthetics 9.Chronic pain conditions: 10.Chronic opioid use (regular opioid use >3 months) 11.Opioid tolerance or dependence 12.Current pain medication exceeding oral morphine equivalent >30 mg/day 13.Inability to understand Thai or English language for pain assessment

Design outcomes

Primary

MeasureTime frame
Postoperative pain intensity at rest 48 hours after surgery Visual Analog Scale (VAS) pain score at rest at 48 hours postoperatively,Time to first analgesic request 0-48 hours postoperatively Duration from end of surgery to first analgesic request

Secondary

MeasureTime frame
Cumulative postoperative morphine consumption 0-24 hours and 0-48 hours postoperatively Total morphine consumption (in mg) at 24 and 48 hours

Countries

Thailand

Contacts

Public ContactHadchaporn kheawbanyang

Phichit hospital

hadchaporn10@gmail.com056611355

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026